• All sections
  • C - Chemistry; metallurgy
  • C07D - Heterocyclic compounds
  • C07D 233/60 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms

Patent holdings for IPC class C07D 233/60

Total number of patents in this class: 412

10-year publication summary

42
30
21
27
23
27
23
30
17
4
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
BASF SE
19740
19
Antecip Bioventures II LLC
300
16
Tokyo Ohka Kogyo Co., Ltd.
1481
10
Cellix Bio Private Limited
67
7
Daicel Corporation
2128
7
The University of British Columbia
1432
7
vTv Therapeutics LLC
159
6
Novartis AG
11238
5
FUJIFILM Corporation
27102
5
Agency for Science, Technology and Research
3512
5
British Columbia Cancer Agency Branch
195
5
Kureha Corporation
1026
5
LG Energy Solution, Ltd.
10813
5
Hoffmann-La Roche Inc.
3060
4
Sumitomo Chemical Company, Limited
8808
4
Henkel AG & Co. KGaA
10129
4
Mitobridge, Inc.
58
4
UDC Ireland Limited
496
4
The United States Government AS represented by The Department of Veterans Affairs
949
4
University of Pittsburgh - Of the Commonwealth System of Higher Education
2912
4
Other owners 282